The Department of Pharmacy at The Johns Hopkins Hospital offers an ASHP – Accredited Residency in Oncology Pharmacy. With over 20 years of experience preparing pharmacists for clinical practice in oncology, this program provides a multidisciplinary environment focusing on education, research and quality patient care, based within The Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins. This twelve-month program is designed to provide concentrated training focused on the care of patients with cancer. Core experiences include inpatient medical oncology, hematologic malignancies, stem cell transplantation, ambulatory experiences in a variety of disease states including solid tumors and hematologic malignancies, and palliative care and pain management. Longitudinal experiences include oncology clinical decision support, formulary management, investigational drug services, and practice management. Examples of elective experiences available include infectious diseases in immunocompromised patients, pediatric oncology, benign hematology, and oncology critical care. Learning experiences are primarily at JHH in East Baltimore, with limited experiences at Johns Hopkins Bayview Medical Center and Green Spring Station locations. Residents will participate in the on-call program/code response, staffing in the oncology pharmacy division, a research project with poster presentation at a national conference, and an ACPE-accredited presentation, in addition to other requirements for successful completion of the program.
There are two residency positions available through the match for 2024-2025.
Note: In addition to completion of an ASHP-accredited PGY1 Pharmacy residency, the resident must be authorized to work in the US. The Johns Hopkins Hospital does not currently sponsor work visas for this position.
Matthew J. Newman, PharmD, MEHP, BCOP
Lead Clinical Pharmacy Specialist, Acute Care Oncology
From the 1889 opening of The Johns Hopkins Hospital, to the opening of the School of Medicine four years later, there emerged the concept of combining research, teaching and patient care. This model, the first of its kind, would lead to a national and international reputation for excellence and discovery.Today, Johns Hopkins uses one overarching name—Johns Hopkins Medicine—to identify its entire medical enterprise. This $6.7 billion system unites the physicians and scientists of the Johns Hopkins University School of Medicine with the health professionals and facilities that make up the broad, integrated Johns Hopkins Health System.